Pregnancy in women with type 1 diabetes (DM 1) is a high-risk group. The aim of our study was to evaluate the results of management of pregnant women with DM 1 using continuous subcutaneous insulin infusion (CSII) in the Republic of Belarus.
The study included pregnant women with DM 1 (n = 102) who were on pump insulin therapy and were delivered in «Mother and Child» National Research Center in 2009-2019. We estimated gestational age, newborn weight, HbA1c level in the third trimester, number of full-term pregnancies.
Gestational age was 38±1.5 weeks (M ± SD), the weight of newborns was 3442±530 g, the level of HbA1c was 5.9±0.8%. The frequency of full-term pregnancies was 86.3% with the duration of DM 1 - 13.3±6.7 years.
Continuous subcutaneous insulin infusion is an effective method of management of pregnant women with DM 1, which allows to achieve optimal compensation of carbohydrate metabolism, and as a result, full-term pregnancy in 86.3% and the birth of healthy children.